Pharma Journalist - Page 31 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

FDA Rejects REGENXBIO Gene Therapy for Hunter Syndrome

Biocodex, THX Pharma Partner on Rare Disease Therapies

Measuring Impact in Medical Affairs Summit: Redefining How Medical Affairs Can Demonstrate its Strategic Value

Everest Medicines Licenses Novel Kidney Disease Drug MT1013

Eisai, Henlius Partner to Bring Serplulimab to Japan

Grünenthal, Apotex Sign Deal for Nebido Canada Rights

PrimeGen US Plans Nasdaq Listing via $1.5B SPAC Deal

CEPI, Samsung Biologics Partner for Rapid Pandemic Vaccine Production

FDA Grants Breakthrough Status to Relay Breast Cancer Therapy

FDA Issues Complete Response Letter for Aquestive Allergy Film